![Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/1d566ba3-d508-4455-9156-8ef1aa950f40/gr6_lrg.jpg)
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet
![Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial - The Lancet Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/1af234a4-42fc-4de2-a2b0-5a5794566dc0/gr1.gif)
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial - The Lancet
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/adda84de-3823-4f70-9084-2c50c6cc9fbc/gr3.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/5d8d4de2-d3d1-4195-9d30-858ed4898f82/gr4_lrg.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission - The Lancet Neurology Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission - The Lancet Neurology](https://www.thelancet.com/cms/attachment/07a466e0-7b9e-4943-94b7-e72f502ca21b/gr1.jpg)
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission - The Lancet Neurology
![The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial - The Lancet The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial - The Lancet](https://www.thelancet.com/cms/asset/56c9d08a-f768-411b-a2b4-9977b63d5474/gr1.jpg)
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial - The Lancet
![Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials - eBioMedicine Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials - eBioMedicine](https://www.thelancet.com/cms/attachment/df0274c8-c59c-4aad-b824-67235a02c790/gr1.jpg)
Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials - eBioMedicine
![Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram](https://www.researchgate.net/publication/350461679/figure/fig1/AS:1012276240850954@1618356871831/Long-term-results-from-the-CHAMPION-trial-Effect-of-pulmonary-artery-pressureguided_Q320.jpg)
Long-term results from the CHAMPION trial: Effect of pulmonary artery... | Download Scientific Diagram
![Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial - The Lancet Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/asset/2a660a52-9124-415e-b61f-2aeadbd432b2/gr2.jpg)
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial - The Lancet
![Frontiers | Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? Frontiers | Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?](https://www.frontiersin.org/files/Articles/1009475/fcvm-09-1009475-HTML/image_m/fcvm-09-1009475-g001.jpg)
Frontiers | Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/0cde970e-bbd5-45de-869f-8b2260d367c8/gr4.jpg)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/aca1c12b-ab3b-4336-9a97-c92a0f7a06c3/gr3_lrg.jpg)
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial - The Lancet
![Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial - The Lancet Oncology Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2108774837/2082609821/gr1.gif)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial - The Lancet Oncology
![Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction | Circulation: Heart Failure Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction | Circulation: Heart Failure](https://www.ahajournals.org/cms/asset/84cc0344-fd8d-4791-ba4a-f45dc3e559f6/935fig01.jpeg)
Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction | Circulation: Heart Failure
![Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/528b6eb1-cfe1-441f-ae09-724d611db7cc/gr4_lrg.jpg)
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet
![Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/ce95f953-850d-4d5a-95e9-76b56b00e117/gr2_lrg.jpg)
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet
![Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet](https://www.thelancet.com/cms/attachment/0d3ed30f-57a7-4e63-9178-bd25050b439f/gr3_lrg.jpg)
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet
![Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2062646893/2065058613/gr1.gif)
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial - The Lancet
![Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial - Abraham - 2021 - ESC Heart Failure - Wiley Online Library Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial - Abraham - 2021 - ESC Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/adf700d2-acc0-4af7-8612-a8dd160721eb/ehf213550-fig-0003-m.jpg)
Patient monitoring across the spectrum of heart failure disease management 10 years after the CHAMPION trial - Abraham - 2021 - ESC Heart Failure - Wiley Online Library
![Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal](https://onlinejcf.com/cms/attachment/6007dc4e-c488-4b92-84ff-ae52c0626121/gr1.jpg)
Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal
![Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring - Journal of Cardiac Failure Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring - Journal of Cardiac Failure](https://onlinejcf.com/cms/attachment/8cda72b6-9459-4989-8f21-5babcfb5d786/gr1.jpg)
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring - Journal of Cardiac Failure
![Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX | Circulation: Cardiovascular Interventions Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/d7726446-a2eb-438b-b7ad-87cac1f57016/circinterventions.120.010390.fig04.jpg)
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX | Circulation: Cardiovascular Interventions
![Life | Free Full-Text | Pulmonary Artery Pressure-Guided Telemonitoring Reduced Pulmonary Artery Pressure but Did Not Result in Higher Doses of Guideline-Directed Medical Therapy–Observations from an Advanced Elderly German Heart Failure Cohort Life | Free Full-Text | Pulmonary Artery Pressure-Guided Telemonitoring Reduced Pulmonary Artery Pressure but Did Not Result in Higher Doses of Guideline-Directed Medical Therapy–Observations from an Advanced Elderly German Heart Failure Cohort](https://www.mdpi.com/life/life-12-00766/article_deploy/html/images/life-12-00766-g001a.png)